miR-873 has been found to be decreased in breast tumors, negatively regulate the activity of estrogen receptor a (ERa) and decrease ERa phosphorylation, resulting in inhibition of cancer cell proliferation and growth (Cui et al., 2015). Here, ESR1 is linked to breast neoplasm.